142 related articles for article (PubMed ID: 33713979)
1. The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study.
Zhou L; Sun H
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101511. PubMed ID: 33713979
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of anxiety/depression rates and their related predictive factors in acute ischemic stroke patients: A 36-month follow-up study.
Liu X; Cheng C; Liu Z; Fan W; Liu C; Liu Y
Medicine (Baltimore); 2021 Dec; 100(50):e28022. PubMed ID: 34918654
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.
Li J; Ma C
Ir J Med Sci; 2023 Dec; 192(6):2621-2629. PubMed ID: 36862310
[TBL] [Abstract][Full Text] [Related]
4. Postoperative anxiety and depression in surgical gastric cancer patients: their longitudinal change, risk factors, and correlation with survival.
Liu P; Wang Z
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356898
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal change and prognostic value of anxiety and depression in coronary heart disease patients.
Wang D; Dai F; Liu W; Ge L; Qi X; Ma G
Ir J Med Sci; 2021 Feb; 190(1):107-116. PubMed ID: 32661829
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Assessment of Prevalence and Risk Factors of Anxiety and Depression among Prostate Cancer Survivors Post-Resection.
Yu R; Li H
Psychiatr Q; 2021 Sep; 92(3):995-1009. PubMed ID: 33409928
[TBL] [Abstract][Full Text] [Related]
7. Anxiety faintly and depression remarkably correlate with recurrence in acute ischemic stroke patients: A study with 3-year longitude evaluation and follow-up.
Luan S; Wu X; Yin S
Medicine (Baltimore); 2022 Jan; 101(3):e28521. PubMed ID: 35060506
[TBL] [Abstract][Full Text] [Related]
8. Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency.
Deng L; Chen B
Ir J Med Sci; 2023 Dec; 192(6):2613-2619. PubMed ID: 36826710
[TBL] [Abstract][Full Text] [Related]
9. A 5-year follow-up assessment of anxiety and depression in postoperative prostate cancer patients: longitudinal progression and prognostic value.
Li X; Zhang Y; Wang Y
Psychol Health Med; 2023 Feb; 28(2):529-539. PubMed ID: 36050900
[TBL] [Abstract][Full Text] [Related]
10. Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.
Hao A; Huang J; Xu X
Ir J Med Sci; 2021 Aug; 190(3):1155-1164. PubMed ID: 33140294
[TBL] [Abstract][Full Text] [Related]
11. Post-surgery anxiety and depression in prostate cancer patients: prevalence, longitudinal progression, and their correlations with survival profiles during a 3-year follow-up.
Hu S; Li L; Wu X; Liu Z; Fu A
Ir J Med Sci; 2021 Nov; 190(4):1363-1372. PubMed ID: 33411223
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China.
Huang X; Zhang TZ; Li GH; Liu L; Xu GQ
Medicine (Baltimore); 2020 Mar; 99(11):e19087. PubMed ID: 32176035
[TBL] [Abstract][Full Text] [Related]
13. Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients.
Wu X; Wang D; Wang D
Front Surg; 2022; 9():1069709. PubMed ID: 36726957
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal evaluation on 3-year change of anxiety and depression, and their risk factors among parents of childhood and adolescence patients with resectable osteosarcoma: A cohort study.
Meng J; Wu J; Zhang X; Guo L; Li H
Medicine (Baltimore); 2022 Oct; 101(42):e30981. PubMed ID: 36281181
[TBL] [Abstract][Full Text] [Related]
15. A nurse-assisted screening and referral program for depression among survivors of colorectal cancer: feasibility study.
Livingston PM; Craike MJ; White VM; Hordern AJ; Jefford M; Botti MA; Lethborg C; Oldroyd JC
Med J Aust; 2010 Sep; 193(S5):S83-7. PubMed ID: 21542453
[TBL] [Abstract][Full Text] [Related]
16. Effect of cognitive behavioral stress management on anxiety, depression, and quality of life in colorectal cancer patients post tumor resection: a randomized, controlled study.
Xia S
Ir J Med Sci; 2023 Aug; 192(4):1637-1644. PubMed ID: 37246173
[TBL] [Abstract][Full Text] [Related]
17. Associations between alcohol consumption and anxiety, depression, and health-related quality of life in colorectal cancer survivors.
Révész D; Bours MJL; Wegdam JA; Keulen ETP; Breukink SO; Slooter GD; Vogelaar FJ; Weijenberg MP; Mols F
J Cancer Surviv; 2022 Oct; 16(5):988-997. PubMed ID: 34529261
[TBL] [Abstract][Full Text] [Related]
18. Depression Symptoms Predict Worse Clinical Response to Etanercept Treatment in Psoriasis Patients.
Jin W; Zhang S; Duan Y
Dermatology; 2019; 235(1):55-64. PubMed ID: 30408786
[TBL] [Abstract][Full Text] [Related]
19. Major depression but not minor to intermediate depression correlates with unfavorable prognosis in surgical colorectal cancer patients underwent adjuvant chemotherapy.
Xia S; Sun M; Liu X
Psychol Health Med; 2020 Mar; 25(3):309-318. PubMed ID: 31397608
[TBL] [Abstract][Full Text] [Related]
20. The effect of reminiscence therapy-involved care on anxiety, depression, life quality and survival in colorectal cancer patients.
Zhou L; Sun H
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101546. PubMed ID: 33554866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
